- Home
- PRQR vs GCO Comparison
PRQR vs GCO Comparison
Compare PRQR & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | GCO |
|---|---|---|
| Founded | 2012 | 1924 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 266.9M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRQR | GCO |
|---|---|---|
| Price | $2.10 | $29.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $8.14 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 566.5K | 166.7K |
| Earning Date | 11-06-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $18,859,556.00 | ★ $2,382,104,000.00 |
| Revenue This Year | N/A | $3.05 |
| Revenue Next Year | $19.56 | $2.17 |
| P/E Ratio | ★ N/A | $7,286.48 |
| Revenue Growth | N/A | ★ 2.76 |
| 52 Week Low | $1.07 | $16.19 |
| 52 Week High | $3.10 | $43.81 |
Technical Indicators
Market Signals| Indicator | PRQR | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 60.60 |
| Support Level | $1.92 | $25.98 |
| Resistance Level | $2.28 | $28.24 |
| Average True Range (ATR) | 0.15 | 1.43 |
| MACD | 0.00 | 0.75 |
| Stochastic Oscillator | 45.03 | 92.46 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.